EcoDrugPlus

Beta-Secretase 1

Ensembl ID : ENSDORG00000013760
Gene Symbol: BACE1
4 Cross references
220 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSDORG00000012652
Gene Symbol: BDKRB1
3 Cross references
149 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSDORG00000012650
Gene Symbol: BDKRB2
3 Cross references
362 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSDORG00000015372
Gene Symbol: CALCRL
3 Cross references
149 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Beta 4 Subunit

Ensembl ID : ENSDORG00000007926
Gene Symbol: CACNB4
1 Cross references
251 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 8

Ensembl ID : ENSDORG00000028300
Gene Symbol: CACNG8
1 Cross references
243 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSDORG00000003162
Gene Symbol: CASR
3 Cross references
203 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSDORG00000001251
Gene Symbol: CACNA2D1
3 Cross references
287 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2

Ensembl ID : ENSDORG00000007866
Gene Symbol: CACNA2D2
3 Cross references
269 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3

Ensembl ID : ENSDORG00000012288
Gene Symbol: CACNA2D3
3 Cross references
213 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Beta 1

Ensembl ID : ENSDORG00000016306
Gene Symbol: CACNB1
4 Cross references
210 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Beta 2

Ensembl ID : ENSDORG00000001954
Gene Symbol: CACNB2
3 Cross references
206 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).